marijuana stocks

Cara reports 4Q loss

Cara Therapeutics posts loss of $4.2 million in 4th quarter

SHELTON, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a fourth-quarter loss of $4.2 million, after reporting a profit in the same period a year earlier.

The Shelton, Connecticut-based company said it had a loss of 18 cents per share.

The biotechnology company posted revenue of $914,000 in the period.

For the year, the company reported that its loss widened to $17.7 million, or 85 cents per share. Revenue was reported as $3.2 million.

Cara shares have fallen nearly 7 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.30, a drop of 45 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

_____

Keywords: Cara Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Curaleaf Holdings, Inc. (CURLF) Opens Two New Pennsylvania Dispensaries

Curaleaf Opens Two New Pennsylvania Dispensaries Curaleaf Holdings, Inc. (CSE: CURA /…

Aurora Cannabis Inc. (ACB) Announces Filing of Preliminary Base Shelf Prospectus

Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus and Provides Update…

Terra Tech Corp. (TRTC) to Present at the 10th Annual LD Micro Main Event on December 6th

Terra Tech Corporation to Present at the 10th Annual LD Micro Main…

Lexaria Bioscience Corp. (LXX.CN) (LXRP) Engages Integra Consulting Group to Provide Investor Relations Services

Lexaria Bioscience Engages Integra Consulting Group to Provide Investor Relations Services  …